ASIX
AdvanSix Inc.
Company overview
- Market capitalization
- $426.08M
- Employees
- 1,410
- Latest publication
- 2026-09-29
About AdvanSix Inc.
AdvanSix Inc., integrated chemistry company, engages in the manufacture and sale of polymer resins in the United States and internationally. The company offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. It also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and resins. In addition, the company offers intermediate chemicals, including phenol, alpha-methylstyrene, cyclohexanone, oximes, cyclohexanol, and alkyl and specialty amines; and cyclohexanol, sulfuric acid, ammonia, and carbon dioxide, as well as automotive components, water treatment, and pharmaceutical intermediates. It offers its products under the Aegis, Sulf-N, Nadone, Naxol, and EZ-Blox under brand names. The company sells its products directly and through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q2 20232023-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 421,284,000USD | 359,947,000USD | 374,473,000USD | 410,022,000USD | 377,791,000USD | 398,187,000USD | 453,479,000USD | 427,940,000USD |
| Cost Of Revenue | 390,183,000USD | 332,577,000USD | 349,088,000USD | 351,308,000USD | 324,320,000USD | 340,885,000USD | 372,111,000USD | 360,017,000USD |
| Gross Profit | 31,101,000USD | 27,370,000USD | 25,385,000USD | 58,714,000USD | 53,471,000USD | 57,302,000USD | 81,368,000USD | 67,923,000USD |
| Selling General Administrative | 22,054,000USD | 28,500,000USD | 27,425,000USD | 25,416,000USD | 23,409,000USD | 24,265,000USD | 24,431,000USD | 24,011,000USD |
| Total Operating Expenses | 22,054,000USD | 28,500,000USD | 27,425,000USD | 25,416,000USD | 23,409,000USD | 24,265,000USD | 24,431,000USD | 24,011,000USD |
| Operating Income | 9,047,000USD | -1,130,000USD | -2,040,000USD | 33,298,000USD | 30,062,000USD | 33,037,000USD | 56,937,000USD | 43,912,000USD |
| Total Other Income Expense Net | -2,393,000USD | -1,471,000USD | -1,507,000USD | -1,648,000USD | -1,133,000USD | -3,292,000USD | -4,865,000USD | -629,000USD |
| Net Interest Income | -2,608,000USD | -2,362,000USD | -2,322,000USD | -2,255,000USD | -1,541,000USD | -2,924,000USD | -3,514,000USD | -1,954,000USD |
| Income Before Tax | 6,654,000USD | -2,601,000USD | -3,547,000USD | 31,650,000USD | 28,929,000USD | 29,745,000USD | 52,072,000USD | 43,283,000USD |
| Income Tax Expense | 3,406,000USD | 190,000USD | -909,000USD | 279,000USD | 5,585,000USD | 7,479,000USD | 13,145,000USD | 10,555,000USD |
| Net Income | 3,248,000USD | -2,791,000USD | -2,638,000USD | 31,371,000USD | 23,344,000USD | 22,266,000USD | 38,927,000USD | 32,728,000USD |
| Interest Expense | — | 2,362,000USD | 2,322,000USD | 2,255,000USD | 1,541,000USD | 2,924,000USD | 3,514,000USD | 1,954,000USD |
| Tax Provision | — | 190,000USD | -909,000USD | 279,000USD | 5,585,000USD | 7,479,000USD | 13,145,000USD | 10,555,000USD |
| Net Income From Continuing Ops | — | -2,791,000USD | -2,638,000USD | 31,371,000USD | 23,344,000USD | 22,266,000USD | 38,927,000USD | 32,728,000USD |
| Ebit | — | -239,000USD | -1,225,000USD | 33,905,000USD | 30,470,000USD | 32,669,000USD | 55,586,000USD | 45,237,000USD |
| Ebitda | — | 20,535,000USD | 19,102,000USD | 53,366,000USD | 49,648,000USD | 51,602,000USD | 74,748,000USD | 63,350,000USD |
| Depreciation And Amortization | — | 20,774,000USD | 20,327,000USD | 19,461,000USD | 19,178,000USD | 18,933,000USD | 19,162,000USD | 18,113,000USD |
| Reconciled Depreciation | — | 20,774,000USD | 20,327,000USD | 19,461,000USD | 19,178,000USD | 18,933,000USD | 19,162,000USD | 18,113,000USD |
| Non Operating Income Net Other | — | — | — | — | — | — | — | 1,325,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | — | 32,728,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,522,233,000USD | 1,517,557,000USD | 1,533,599,000USD | 1,945,640,000USD | 1,684,625,000USD | 1,157,917,000USD | 1,297,393,000USD | 1,514,984,000USD |
| Cost Of Revenue | 1,348,593,000USD | 1,364,621,000USD | 1,368,511,000USD | 1,631,161,000USD | 1,410,503,000USD | 1,024,169,000USD | 1,161,921,000USD | 1,340,497,000USD |
| Gross Profit | 173,640,000USD | 152,936,000USD | 165,088,000USD | 314,479,000USD | 274,122,000USD | 133,748,000USD | 135,472,000USD | 174,487,000USD |
| Research Development | 8,700,000USD | 8,800,000USD | 9,800,000USD | 12,500,000USD | 14,000,000USD | 11,800,000USD | 13,900,000USD | 14,800,000USD |
| Selling General Administrative | 104,750,000USD | 94,023,000USD | 95,538,000USD | 87,748,000USD | 82,985,000USD | 70,870,000USD | 75,375,000USD | 81,224,000USD |
| Unclassified Operating Expenses | -7,325,000USD | -8,800,000USD | -9,800,000USD | -12,500,000USD | -14,000,000USD | 51,078,000USD | -13,900,000USD | -14,800,000USD |
| Total Operating Expenses | 106,125,000USD | 94,023,000USD | 95,538,000USD | 87,748,000USD | 82,985,000USD | 133,748,000USD | 75,375,000USD | 81,224,000USD |
| Operating Income | 67,515,000USD | 58,913,000USD | 69,550,000USD | 226,731,000USD | 191,137,000USD | 62,825,000USD | 60,097,000USD | 93,263,000USD |
| Interest Expense | 8,481,000USD | 11,311,000USD | 7,485,000USD | 2,781,000USD | 5,023,000USD | 7,792,000USD | 6,749,000USD | 7,492,000USD |
| Net Interest Income | -8,481,000USD | -11,311,000USD | -7,485,000USD | -2,781,000USD | -5,023,000USD | -7,792,000USD | — | — |
| Income Before Tax | 54,431,000USD | 45,575,000USD | 69,223,000USD | 225,791,000USD | 185,116,000USD | 55,033,000USD | 53,348,000USD | 85,768,000USD |
| Income Tax Expense | 5,145,000USD | 1,426,000USD | 14,600,000USD | 53,905,000USD | 45,325,000USD | 8,956,000USD | 12,001,000USD | 19,524,000USD |
| Tax Provision | 5,145,000USD | 1,426,000USD | 14,600,000USD | 53,905,000USD | 45,325,000USD | 8,956,000USD | 12,001,000USD | 19,524,000USD |
| Net Income | 49,286,000USD | 44,149,000USD | 54,623,000USD | 171,886,000USD | 139,791,000USD | 46,077,000USD | 41,347,000USD | 66,244,000USD |
| Net Income From Continuing Ops | 49,286,000USD | 44,149,000USD | 54,623,000USD | 171,886,000USD | 139,791,000USD | 46,077,000USD | 41,347,000USD | 66,244,000USD |
| Ebit | 62,912,000USD | 56,886,000USD | 76,708,000USD | 228,572,000USD | 190,139,000USD | 62,825,000USD | 58,802,000USD | 85,768,000USD |
| Ebitda | 142,652,000USD | 133,062,000USD | 149,718,000USD | 297,925,000USD | 255,479,000USD | 123,657,000USD | 115,628,000USD | 139,001,000USD |
| Depreciation And Amortization | 79,740,000USD | 76,176,000USD | 73,010,000USD | 69,353,000USD | 65,340,000USD | 60,832,000USD | 56,826,000USD | 53,233,000USD |
| Reconciled Depreciation | 79,740,000USD | 76,176,000USD | 73,010,000USD | 69,353,000USD | 65,340,000USD | 60,832,000USD | 56,826,000USD | 53,233,000USD |
| Total Other Income Expense Net | -13,084,000USD | -13,338,000USD | -327,000USD | -940,000USD | -6,021,000USD | 55,033,000USD | -6,749,000USD | -7,495,000USD |
| Non Operating Income Net Other | — | — | — | 1,841,000USD | -998,000USD | -53,000USD | -6,749,000USD | -7,495,000USD |
| Net Income Applicable To Common Shares | — | — | — | 171,886,000USD | 139,791,000USD | 46,077,000USD | 41,347,000USD | 66,244,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,673,016,000USD | 1,710,753,000USD | 1,706,148,000USD | 1,688,347,000USD | 1,646,402,000USD | 1,625,974,000USD | 1,594,920,000USD | 1,510,235,000USD |
| Cash And Equivalents | 7,217,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 424,861,000USD | 453,991,000USD | 440,607,000USD | 454,995,000USD | 434,176,000USD | 418,182,000USD | 387,116,000USD | 395,773,000USD |
| Other Current Assets | 15,560,000USD | 5,360,000USD | 8,639,000USD | 13,931,000USD | 19,021,000USD | 7,645,000USD | 8,990,000USD | 15,608,000USD |
| Other Non Current Assets | 41,072,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 876,104,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 331,739,000USD | 370,432,000USD | 389,951,000USD | 334,328,000USD | 321,067,000USD | 350,946,000USD | 357,103,000USD | 295,142,000USD |
| Other Current Liabilities | 43,558,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 796,912,000USD | 796,289,000USD | 815,216,000USD | 818,232,000USD | 823,732,000USD | 794,368,000USD | 774,650,000USD | 766,408,000USD |
| Total Equity Including Noncontrolling Interest | 796,912,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 1,980,000USD | — | — | — | — | — | — | — |
| Inventory | 194,145,000USD | 201,358,000USD | 236,495,000USD | 209,120,000USD | 221,764,000USD | 222,857,000USD | 212,386,000USD | 213,434,000USD |
| Property Plant Equipment Net | 1,112,321,000USD | 1,120,131,000USD | 1,128,212,000USD | 1,098,984,000USD | 1,073,197,000USD | 1,070,850,000USD | 1,071,296,000USD | 983,314,000USD |
| Goodwill | 56,192,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 38,570,000USD | 39,333,000USD | 40,095,000USD | 40,857,000USD | 41,619,000USD | 42,382,000USD | 43,144,000USD | 43,906,000USD |
| Accounts Payable | 243,287,000USD | 284,334,000USD | 284,016,000USD | 236,053,000USD | 231,907,000USD | 238,906,000USD | 228,761,000USD | 207,272,000USD |
| Short Term Debt | 42,841,000USD | 43,670,000USD | 45,299,000USD | 41,695,000USD | 38,718,000USD | 40,093,000USD | 42,493,000USD | 30,135,000USD |
| Common Stock | 334,000USD | 334,000USD | 332,000USD | 332,000USD | 332,000USD | 331,000USD | 330,000USD | 330,000USD |
| Retained Earnings | 641,669,000USD | 642,949,000USD | 663,019,000USD | 670,264,000USD | 677,354,000USD | 650,435,000USD | 631,541,000USD | 635,609,000USD |
| Accumulated Other Comprehensive Income | 8,982,000USD | 9,004,000USD | 8,996,000USD | 5,823,000USD | 6,012,000USD | 5,988,000USD | 5,970,000USD | -4,203,000USD |
| Total Liab | — | 914,464,000USD | 890,932,000USD | 870,115,000USD | 822,670,000USD | 831,606,000USD | 820,270,000USD | 743,827,000USD |
| Other Current Liab | — | 30,546,000USD | 45,000,000USD | 55,899,000USD | 48,200,000USD | 42,775,000USD | 47,264,000USD | 55,783,000USD |
| Capital Stock | — | 334,000USD | 332,000USD | 332,000USD | 332,000USD | 331,000USD | 330,000USD | 330,000USD |
| Good Will | — | 56,192,000USD | 56,192,000USD | 56,192,000USD | 56,192,000USD | 56,192,000USD | 56,192,000USD | 56,192,000USD |
| Cash | — | 17,574,000USD | 19,766,000USD | 23,696,000USD | 18,446,000USD | 8,344,000USD | 19,564,000USD | 17,298,000USD |
| Cash And Short Term Investments | — | 17,574,000USD | 19,766,000USD | 23,696,000USD | 18,446,000USD | 8,344,000USD | 19,564,000USD | 17,298,000USD |
| Current Deferred Revenue | — | 11,303,000USD | 14,536,000USD | 681,000USD | 1,858,000USD | 26,582,000USD | 37,538,000USD | 1,517,000USD |
| Net Debt | — | 408,786,000USD | 362,928,000USD | 382,923,000USD | 359,309,000USD | 352,186,000USD | 329,329,000USD | 288,630,000USD |
| Short Long Term Debt Total | — | 426,360,000USD | 382,694,000USD | 406,619,000USD | 377,755,000USD | 360,530,000USD | 348,893,000USD | 305,928,000USD |
| Long Term Debt | — | 270,000,000USD | 215,000,000USD | 250,000,000USD | 240,000,000USD | 215,000,000USD | 195,000,000USD | 215,000,000USD |
| Net Receivables | — | 229,699,000USD | 175,707,000USD | 208,248,000USD | 174,945,000USD | 179,336,000USD | 146,176,000USD | 149,433,000USD |
| Property Plant Equipment Gross | — | 1,120,131,000USD | 2,306,152,000USD | 1,098,984,000USD | 1,073,197,000USD | 1,070,850,000USD | 2,203,848,000USD | 983,314,000USD |
| Common Stock Shares Outstanding | — | 26,980,742shares | 26,941,274shares | 27,248,759shares | 27,249,000shares | 27,289,000shares | 27,235,000shares | 27,205,000shares |
| Non Current Assets Total | — | 1,256,762,000USD | 1,265,541,000USD | 1,233,351,999USD | 1,212,226,000USD | 1,207,792,000USD | 1,207,804,000USD | 1,114,462,000USD |
| Non Current Liabilities Total | — | 544,032,000USD | 500,981,000USD | 535,787,000USD | 501,603,000USD | 480,660,000USD | 463,167,000USD | 448,685,000USD |
| Non Current Liabilities Other | — | 10,701,000USD | 10,719,000USD | 10,848,000USD | 10,628,000USD | 10,877,000USD | 11,468,000USD | 11,154,000USD |
| Non Currrent Assets Other | — | 41,106,000USD | 41,042,000USD | 37,318,999USD | 41,218,000USD | 38,368,000USD | 37,172,000USD | 31,050,000USD |
| Net Working Capital | — | 83,559,000USD | 50,656,000USD | 120,667,000USD | 113,109,000USD | 67,236,000USD | 30,013,000USD | 100,631,000USD |
| Unclassified Non Current Liabilities | — | 263,331,000USD | 275,262,000USD | 274,939,000USD | 250,975,000USD | 254,783,000USD | 256,699,000USD | 222,531,000USD |
| Unclassified Equity | — | 143,668,000USD | 142,537,000USD | 141,481,000USD | 139,702,000USD | 137,283,000USD | 136,479,000USD | 134,342,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,706,148,000USD | 1,594,920,000USD | 1,496,020,000USD | 1,495,331,000USD | 1,311,999,000USD | 1,263,407,000USD | 1,235,969,000USD | 1,034,626,000USD |
| Intangible Assets | 40,095,000USD | 43,144,000USD | 46,193,000USD | 49,242,000USD | 17,980,000USD | — | — | — |
| Other Current Assets | 8,639,000USD | 8,990,000USD | 11,378,000USD | 9,241,000USD | 6,097,000USD | 6,969,000USD | 5,117,000USD | 3,807,000USD |
| Total Liab | 890,932,000USD | 820,270,000USD | 756,783,000USD | 757,151,000USD | 710,809,000USD | 819,284,000USD | 835,091,000USD | 614,288,000USD |
| Total Stockholder Equity | 815,216,000USD | 774,650,000USD | 739,237,000USD | 738,180,000USD | 601,190,000USD | 444,123,000USD | 400,878,000USD | 420,338,000USD |
| Other Current Liab | 45,000,000USD | 47,264,000USD | 44,086,000USD | 48,820,000USD | 49,712,000USD | 41,152,000USD | 28,114,000USD | 30,448,000USD |
| Common Stock | 332,000USD | 330,000USD | 326,000USD | 320,000USD | 318,000USD | 316,000USD | 314,000USD | 306,000USD |
| Capital Stock | 332,000USD | 330,000USD | 326,000USD | 320,000USD | 318,000USD | 316,000USD | 314,000USD | 306,000USD |
| Retained Earnings | 663,019,000USD | 631,541,000USD | 605,067,000USD | 567,517,000USD | 411,516,000USD | 275,243,000USD | 229,166,000USD | 187,819,000USD |
| Good Will | 56,192,000USD | 56,192,000USD | 56,192,000USD | 56,192,000USD | 17,592,000USD | 15,005,000USD | 15,005,000USD | 15,005,000USD |
| Cash | 19,766,000USD | 19,564,000USD | 29,768,000USD | 30,985,000USD | 15,100,000USD | 10,606,000USD | 7,050,000USD | 9,808,000USD |
| Cash And Short Term Investments | 19,766,000USD | 19,564,000USD | 29,768,000USD | 30,985,000USD | 15,100,000USD | 10,606,000USD | 7,050,000USD | 9,808,000USD |
| Total Current Assets | 440,607,000USD | 387,116,000USD | 419,804,000USD | 440,928,000USD | 349,854,000USD | 333,503,000USD | 290,537,000USD | 311,063,000USD |
| Total Current Liabilities | 389,951,000USD | 357,103,000USD | 358,918,000USD | 393,492,000USD | 309,822,000USD | 287,037,000USD | 291,726,000USD | 284,724,000USD |
| Current Deferred Revenue | 14,536,000USD | 37,538,000USD | 15,678,000USD | 34,430,000USD | 2,749,000USD | 26,379,000USD | 19,696,000USD | 22,556,000USD |
| Net Debt | 362,928,000USD | 329,329,000USD | 236,246,000USD | 199,058,000USD | 256,607,000USD | 379,278,000USD | 426,302,000USD | 190,192,000USD |
| Short Term Debt | 45,299,000USD | 42,493,000USD | 32,053,000USD | 37,472,000USD | 36,127,000USD | 29,279,000USD | 38,005,000USD | 2,212,000USD |
| Short Long Term Debt Total | 382,694,000USD | 348,893,000USD | 266,014,000USD | 230,043,000USD | 271,707,000USD | 389,884,000USD | 433,352,000USD | 202,212,000USD |
| Long Term Debt | 215,000,000USD | 195,000,000USD | 170,000,000USD | 115,000,000USD | 135,000,000USD | 275,000,000USD | 297,000,000USD | 200,000,000USD |
| Net Receivables | 175,707,000USD | 146,176,000USD | 166,827,000USD | 185,200,000USD | 179,087,000USD | 135,843,000USD | 106,660,000USD | 160,266,000USD |
| Inventory | 236,495,000USD | 212,386,000USD | 211,831,000USD | 215,502,000USD | 149,570,000USD | 180,085,000USD | 171,710,000USD | 137,182,000USD |
| Accounts Payable | 284,016,000USD | 228,761,000USD | 259,068,000USD | 272,740,000USD | 221,234,000USD | 190,227,000USD | 205,911,000USD | 229,508,000USD |
| Property Plant Equipment Net | 1,128,212,000USD | 1,071,296,000USD | 948,447,000USD | 925,753,000USD | 904,171,000USD | 879,953,000USD | 891,866,000USD | 672,210,000USD |
| Property Plant Equipment Gross | 2,306,152,000USD | 2,203,848,000USD | 2,024,456,000USD | 925,753,000USD | 904,171,000USD | 879,953,000USD | 891,866,000USD | 672,210,000USD |
| Accumulated Other Comprehensive Income | 8,996,000USD | 5,970,000USD | -4,144,000USD | -4,197,000USD | -6,539,000USD | -16,132,000USD | -9,451,000USD | -2,474,000USD |
| Common Stock Shares Outstanding | 27,327,449shares | 27,255,000shares | 28,007,630shares | 29,031,107shares | 29,045,186shares | 28,157,062shares | 28,898,836shares | 30,978,291shares |
| Non Current Assets Total | 1,265,541,000USD | 1,207,804,000USD | 1,076,216,000USD | 1,054,403,000USD | 962,145,000USD | 929,904,000USD | 945,432,000USD | 723,563,000USD |
| Non Current Liabilities Total | 500,981,000USD | 463,167,000USD | 397,865,000USD | 363,659,000USD | 400,987,000USD | 532,247,000USD | 543,365,000USD | 329,564,000USD |
| Non Current Liabilities Other | 10,719,000USD | 11,468,000USD | 9,185,000USD | 10,679,000USD | 132,657,000USD | 131,672,000USD | 5,537,000USD | 4,701,000USD |
| Non Currrent Assets Other | 41,042,000USD | 37,172,000USD | 25,384,000USD | 23,216,000USD | 22,402,000USD | 34,946,000USD | 38,561,000USD | 36,348,000USD |
| Net Working Capital | 50,656,000USD | 30,013,000USD | 60,886,000USD | 47,436,000USD | 40,032,000USD | 46,466,000USD | -1,189,000USD | 26,339,000USD |
| Unclassified Non Current Liabilities | 275,262,000USD | 256,699,000USD | 218,680,000USD | -92,529,000USD | -165,407,000USD | -171,642,000USD | -16,553,000USD | -108,052,000USD |
| Unclassified Equity | 142,537,000USD | 136,479,000USD | 137,662,000USD | 174,265,000USD | 195,613,000USD | 184,416,000USD | 180,570,000USD | 234,393,000USD |
| Unclassified Current Liabilities | — | — | 8,033,000USD | — | — | — | — | — |
| Deferred Long Term Liab | — | — | — | 160,409,000USD | 133,330,000USD | 125,575,000USD | 110,071,000USD | 103,783,000USD |
| Other Liab | — | — | — | 170,100,000USD | 165,407,000USD | 171,642,000USD | 147,310,000USD | 129,132,000USD |
| Other Assets | — | — | — | 23,216,000USD | 40,382,000USD | 34,946,000USD | 38,561,000USD | 36,348,000USD |
| Treasury Stock | — | — | — | -45,000USD | -36,000USD | -36,000USD | -35,000USD | -12,000USD |
| Net Tangible Assets | — | — | — | 632,746,000USD | 583,598,000USD | 429,118,000USD | 385,873,000USD | 405,333,000USD |
| Unclassified Non Current Assets | — | — | — | -23,216,000USD | -40,382,000USD | -34,946,000USD | -38,561,000USD | -36,348,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 1,500,000USD |
| Stock Based Compensation | 3,878,000USD |
| Deferred Income Tax | -1,889,000USD |
| Change To Inventory | 42,350,000USD |
| Change To Liabilities | -24,935,000USD |
| Change In Working Capital | 18,389,000USD |
| Operating Cash Flow | -5,294,000USD |
| Capital Expenditures | -56,650,000USD |
| Other Investing Activities | 222,000USD |
| Unclassified Investing Cash Flow | -444,000USD |
| Investing Cash Flow | -56,872,000USD |
| Net Debt Issuance | -513,000USD |
| Net Common Stock Issuance | -1,397,000USD |
| Common Dividends Paid | -8,627,000USD |
| Unclassified Financing Cash Flow | 60,154,000USD |
| Financing Cash Flow | 49,617,000USD |
| Change In Cash | -12,549,000USD |
| End Cash Flow | 7,217,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -15,546,000USD | -2,791,000USD | -2,638,000USD | 31,371,000USD | 23,344,000USD | 352,000USD | 22,266,000USD | 38,927,000USD |
| Depreciation | 20,958,000USD | 20,774,000USD | 20,327,000USD | 19,461,000USD | 19,178,000USD | 18,979,000USD | 18,933,000USD | 19,162,000USD |
| Stock Based Compensation | 2,045,000USD | 902,000USD | 1,632,000USD | 2,309,000USD | 1,978,000USD | 1,891,000USD | 1,559,000USD | 2,193,000USD |
| Other Non Cash Items | 127,000USD | 229,000USD | 155,000USD | 187,000USD | -55,000USD | 512,000USD | 309,000USD | 1,526,000USD |
| Change To Account Receivables | -53,984,000USD | 32,729,000USD | -33,492,000USD | 4,470,000USD | -33,204,000USD | 3,214,000USD | 20,877,000USD | -357,000USD |
| Change To Inventory | 35,137,000USD | -27,375,000USD | 12,644,000USD | 1,093,000USD | -10,471,000USD | 1,048,000USD | -37,607,000USD | 15,094,000USD |
| Change In Working Capital | -19,496,000USD | 51,253,000USD | -708,000USD | -34,810,000USD | -37,056,000USD | 55,060,000USD | 11,296,000USD | -11,251,000USD |
| Total Cash From Operating Activities | -15,332,000USD | 63,722,000USD | 26,588,000USD | 21,110,000USD | 11,443,000USD | 64,165,000USD | 57,250,000USD | 50,200,000USD |
| Capital Expenditures | -35,936,000USD | -27,596,000USD | -26,522,000USD | -28,265,000USD | -34,062,000USD | -34,349,000USD | -30,490,000USD | -33,495,000USD |
| Free Cash Flow | -51,268,000USD | 36,126,000USD | 66,000USD | -7,155,000USD | -22,619,000USD | 29,816,000USD | 26,760,000USD | 16,705,000USD |
| Total Cashflows From Investing Activities | -36,163,000USD | -27,612,000USD | -26,784,000USD | -31,424,000USD | -36,794,000USD | -37,476,000USD | -32,807,000USD | -35,812,000USD |
| Net Borrowings | 54,737,000USD | -35,262,000USD | 9,751,000USD | 24,756,000USD | 19,753,000USD | -20,249,000USD | -15,260,000USD | — |
| Total Cash From Financing Activities | 49,303,000USD | -40,040,000USD | 5,446,000USD | 20,416,000USD | 14,131,000USD | -24,423,000USD | -19,250,000USD | -22,916,000USD |
| Dividends Paid | -4,313,000USD | -4,300,000USD | -4,296,000USD | -4,290,000USD | -4,290,000USD | -4,277,000USD | -4,276,000USD | -4,292,000USD |
| Sale Purchase Of Stock | -1,275,000USD | 0USD | -121,000USD | -51,000USD | -1,486,000USD | -1,000USD | -42,000USD | -3,362,000USD |
| Issuance Of Capital Stock | 154,000USD | 0USD | 112,000USD | 1,000USD | 154,000USD | 104,000USD | 328,000USD | 1,000USD |
| Change In Cash | -2,192,000USD | -3,930,000USD | 5,250,000USD | 10,102,000USD | -11,220,000USD | 2,266,000USD | 5,193,000USD | -8,528,000USD |
| Begin Period Cash Flow | 19,766,000USD | 23,696,000USD | 18,446,000USD | 8,344,000USD | 19,564,000USD | 17,298,000USD | 12,105,000USD | 20,633,000USD |
| End Period Cash Flow | 17,574,000USD | 19,766,000USD | 23,696,000USD | 18,446,000USD | 8,344,000USD | 19,564,000USD | 17,298,000USD | 12,105,000USD |
| Other Cashflows From Investing Activities | -227,000USD | -16,000USD | -262,000USD | -3,159,000USD | -2,732,000USD | -3,127,000USD | -2,317,000USD | -2,317,000USD |
| Other Cashflows From Financing Activities | 53,616,000USD | -478,000USD | 9,742,000USD | 24,949,000USD | 18,421,000USD | -20,249,000USD | -32,807,000USD | -35,812,000USD |
| Unclassified Operating Cash Flow | -3,420,000USD | -6,645,000USD | 7,820,000USD | 2,592,000USD | 4,054,000USD | -12,629,000USD | 2,887,000USD | — |
| Unclassified Financing Cash Flow | -53,462,000USD | — | -9,630,000USD | -24,948,000USD | -18,267,000USD | 20,353,000USD | 33,135,000USD | 20,550,000USD |
| Investments | — | — | -26,784,000USD | -31,424,000USD | -36,794,000USD | -37,476,000USD | -32,807,000USD | -35,812,000USD |
| Unclassified Investing Cash Flow | — | — | 26,784,000USD | 31,424,000USD | 36,794,000USD | 37,476,000USD | 32,807,000USD | 35,812,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 49,286,000USD | 44,149,000USD | 54,623,000USD | 171,886,000USD | 139,791,000USD | 46,077,000USD | 41,347,000USD | 66,244,000USD |
| Depreciation | 79,740,000USD | 76,176,000USD | 73,010,000USD | 69,353,000USD | 65,340,000USD | 60,832,000USD | 56,826,000USD | 53,233,000USD |
| Stock Based Compensation | 6,821,000USD | 7,854,000USD | 8,313,000USD | 10,279,000USD | 11,299,000USD | 4,902,000USD | 8,349,000USD | 10,131,000USD |
| Other Non Cash Items | 516,000USD | 2,591,000USD | -2,573,000USD | 2,139,000USD | 2,388,000USD | 1,249,000USD | 16,637,000USD | 3,794,000USD |
| Change To Account Receivables | -29,497,000USD | 19,342,000USD | 29,826,000USD | 17,842,000USD | -53,772,000USD | -18,990,000USD | 53,676,000USD | 31,812,000USD |
| Change To Inventory | -24,109,000USD | -555,000USD | 3,286,000USD | -57,043,000USD | 31,227,000USD | -8,375,000USD | -35,567,000USD | -7,974,000USD |
| Change In Working Capital | -21,321,000USD | 13,634,000USD | -6,476,000USD | 3,716,000USD | -4,671,000USD | -18,824,000USD | -11,216,000USD | 30,425,000USD |
| Total Cash From Operating Activities | 122,863,000USD | 135,413,000USD | 117,550,000USD | 273,601,000USD | 218,849,000USD | 111,847,000USD | 120,385,000USD | 173,385,000USD |
| Capital Expenditures | -116,445,000USD | -133,722,000USD | -107,377,000USD | -89,449,000USD | -56,811,000USD | -82,918,000USD | -150,322,000USD | -109,215,000USD |
| Free Cash Flow | 6,418,000USD | 1,691,000USD | 10,173,000USD | 184,152,000USD | 162,038,000USD | 28,929,000USD | -29,937,000USD | 64,170,000USD |
| Total Cashflows From Investing Activities | -122,614,000USD | -142,902,000USD | -110,897,000USD | -189,273,000USD | -67,562,000USD | -84,103,000USD | -153,125,000USD | -112,191,000USD |
| Net Borrowings | 18,998,000USD | 23,989,000USD | 54,062,000USD | -20,000,000USD | -140,000,000USD | -23,135,000USD | 92,161,000USD | -66,933,000USD |
| Total Cash From Financing Activities | -47,000USD | -2,715,000USD | -7,870,000USD | -68,443,000USD | -146,793,000USD | -24,188,000USD | 29,982,000USD | -106,818,000USD |
| Dividends Paid | -17,176,000USD | -17,135,000USD | -16,657,000USD | -15,073,000USD | -3,518,000USD | -364,000,000USD | -3,518,000USD | -3,518,000USD |
| Sale Purchase Of Stock | -1,658,000USD | -10,428,000USD | -46,151,000USD | -33,748,000USD | -652,000USD | -1,055,000USD | -62,196,000USD | -38,524,000USD |
| Issuance Of Capital Stock | 267,000USD | 859,000USD | 1,134,000USD | 1,304,000USD | 554,000USD | 2,000USD | 17,000USD | — |
| Change In Cash | 202,000USD | -10,204,000USD | -1,217,000USD | 15,885,000USD | 4,494,000USD | 3,556,000USD | -2,758,000USD | -45,624,000USD |
| Begin Period Cash Flow | 19,564,000USD | 29,768,000USD | 30,985,000USD | 15,100,000USD | 10,606,000USD | 7,050,000USD | 9,808,000USD | 55,432,000USD |
| End Period Cash Flow | 19,766,000USD | 19,564,000USD | 29,768,000USD | 30,985,000USD | 15,100,000USD | 10,606,000USD | 7,050,000USD | 9,808,000USD |
| Other Cashflows From Investing Activities | -6,169,000USD | -9,180,000USD | -3,520,000USD | -99,824,000USD | -10,751,000USD | -1,185,000USD | -2,803,000USD | -2,976,000USD |
| Other Cashflows From Financing Activities | 17,129,000USD | 23,989,000USD | 108,124,000USD | 434,500,000USD | 173,558,000USD | 727,575,000USD | 419,250,000USD | 343,639,000USD |
| Unclassified Operating Cash Flow | 7,821,000USD | -8,991,000USD | -9,347,000USD | 16,228,000USD | 4,702,000USD | 17,611,000USD | 8,442,000USD | 9,558,000USD |
| Unclassified Financing Cash Flow | -17,340,000USD | -23,130,000USD | -107,248,000USD | -434,122,000USD | -176,181,000USD | -363,573,000USD | -415,715,000USD | -341,482,000USD |
| Investments | — | -142,902,000USD | -100,649,000USD | -189,273,000USD | -67,562,000USD | -84,103,000USD | -153,125,000USD | -112,191,000USD |
| Unclassified Investing Cash Flow | — | 142,902,000USD | 100,649,000USD | 189,273,000USD | 67,562,000USD | 84,103,000USD | 153,125,000USD | 112,191,000USD |
| Change To Liabilities | — | — | — | 43,048,000USD | 40,047,000USD | 12,555,000USD | -24,894,000USD | -3,831,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 15,885,000USD | 4,494,000USD | 3,556,000USD | -2,758,000USD | -45,624,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | International | 66,962,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | United States | 354,322,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Caprolactam | 62,644,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Chemical Intermediates | 126,983,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Nylon Resins | 100,218,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Plant Nutrients | 131,439,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | International | 68,187,000 | USD | 0001673985-26-000037 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 335,996,000 | USD | 0001673985-26-000037 |
| Q1 2026Quarterly · 2026-03-31 | Product | Caprolactam | 67,768,000 | USD | 0001673985-26-000037 |
| Q1 2026Quarterly · 2026-03-31 | Product | Chemical Intermediates | 107,313,000 | USD | 0001673985-26-000037 |
| Q1 2026Quarterly · 2026-03-31 | Product | Nylon Resins | 88,467,000 | USD | 0001673985-26-000037 |
| Q1 2026Quarterly · 2026-03-31 | Product | Plant Nutrients | 140,635,000 | USD | 0001673985-26-000037 |
| Q4 2025Quarterly · 2025-12-31 | Geography | International | 53,056,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Geography | United States | 306,891,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Caprolactam | 64,377,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Chemical Intermediates | 92,776,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Nylon Resins | 62,777,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Plant Nutrients | 140,017,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | International | 212,478,000 | USD | 0001673985-26-000008 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 1,309,755,000 | USD | 0001673985-26-000008 |
| FY 2025Yearly · 2025-12-31 | Product | Caprolactam | 271,370,000 | USD | 0001673985-26-000008 |
| FY 2025Yearly · 2025-12-31 | Product | Chemical Intermediates | 377,497,000 | USD | 0001673985-26-000008 |
| FY 2025Yearly · 2025-12-31 | Product | Nylon Resins | 309,678,000 | USD | 0001673985-26-000008 |
| FY 2025Yearly · 2025-12-31 | Product | Plant Nutrients | 563,688,000 | USD | 0001673985-26-000008 |
| Q3 2025Quarterly · 2025-09-30 | Geography | International | 50,727,000 | USD | 0001673985-25-000135 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 323,746,000 | USD | 0001673985-25-000135 |
| Q3 2025Quarterly · 2025-09-30 | Product | Caprolactam | 73,137,000 | USD | 0001673985-25-000135 |
| Q3 2025Quarterly · 2025-09-30 | Product | Chemical Intermediates | 83,646,000 | USD | 0001673985-25-000135 |
| Q3 2025Quarterly · 2025-09-30 | Product | Nylon Resins | 79,029,000 | USD | 0001673985-25-000135 |
| Q3 2025Quarterly · 2025-09-30 | Product | Plant Nutrients | 138,661,000 | USD | 0001673985-25-000135 |
| Q2 2025Quarterly · 2025-06-30 | Geography | International | 51,351,000 | USD | 0001673985-25-000119 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 358,671,000 | USD | 0001673985-25-000119 |
| Q2 2025Quarterly · 2025-06-30 | Product | Caprolactam | 66,424,000 | USD | 0001673985-25-000119 |
| Q2 2025Quarterly · 2025-06-30 | Product | Chemical Intermediates | 107,325,000 | USD | 0001673985-25-000119 |
| Q2 2025Quarterly · 2025-06-30 | Product | Nylon Resins | 79,503,000 | USD | 0001673985-25-000119 |
| Q2 2025Quarterly · 2025-06-30 | Product | Plant Nutrients | 156,770,000 | USD | 0001673985-25-000119 |
| Q1 2025Quarterly · 2025-03-31 | Geography | International | 57,344,000 | USD | 0001673985-26-000037 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 320,447,000 | USD | 0001673985-26-000037 |
| Q1 2025Quarterly · 2025-03-31 | Product | Caprolactam | 67,432,000 | USD | 0001673985-26-000037 |
| Q1 2025Quarterly · 2025-03-31 | Product | Chemical Intermediates | 93,750,000 | USD | 0001673985-26-000037 |
| Q1 2025Quarterly · 2025-03-31 | Product | Nylon Resins | 88,369,000 | USD | 0001673985-26-000037 |
| Q1 2025Quarterly · 2025-03-31 | Product | Plant Nutrients | 128,240,000 | USD | 0001673985-26-000037 |
| Q4 2024Quarterly · 2024-12-31 | Geography | International | 50,432,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Geography | United States | 278,630,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Caprolactam | 57,186,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Chemical Intermediates | 102,109,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Nylon Resins | 67,202,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Plant Nutrients | 102,565,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | International | 212,586,000 | USD | 0001673985-26-000008 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 1,304,971,000 | USD | 0001673985-26-000008 |
| FY 2024Yearly · 2024-12-31 | Product | Caprolactam | 276,303,000 | USD | 0001673985-26-000008 |
| FY 2024Yearly · 2024-12-31 | Product | Chemical Intermediates | 434,601,000 | USD | 0001673985-26-000008 |
| FY 2024Yearly · 2024-12-31 | Product | Nylon Resins | 348,501,000 | USD | 0001673985-26-000008 |
| FY 2024Yearly · 2024-12-31 | Product | Plant Nutrients | 458,152,000 | USD | 0001673985-26-000008 |
| Q3 2024Quarterly · 2024-09-30 | Geography | International | 58,292,000 | USD | 0001673985-25-000135 |
| Q3 2024Quarterly · 2024-09-30 | Geography | United States | 339,895,000 | USD | 0001673985-25-000135 |
| Q3 2024Quarterly · 2024-09-30 | Product | Caprolactam | 76,338,000 | USD | 0001673985-25-000135 |
| Q3 2024Quarterly · 2024-09-30 | Product | Chemical Intermediates | 114,604,000 | USD | 0001673985-25-000135 |
| Q3 2024Quarterly · 2024-09-30 | Product | Nylon Resins | 93,693,000 | USD | 0001673985-25-000135 |
| Q3 2024Quarterly · 2024-09-30 | Product | Plant Nutrients | 113,552,000 | USD | 0001673985-25-000135 |
| FY 2023Yearly · 2023-12-31 | Geography | International | 283,505,000 | USD | 0001673985-26-000008 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 1,250,094,000 | USD | 0001673985-26-000008 |
| FY 2023Yearly · 2023-12-31 | Product | Caprolactam | 298,375,000 | USD | 0001673985-26-000008 |
| FY 2023Yearly · 2023-12-31 | Product | Chemical Intermediates | 400,663,000 | USD | 0001673985-26-000008 |
| FY 2023Yearly · 2023-12-31 | Product | Nylon Resins | 356,632,000 | USD | 0001673985-26-000008 |
| FY 2023Yearly · 2023-12-31 | Product | Plant Nutrients | 477,929,000 | USD | 0001673985-26-000008 |
| FY 2022Yearly · 2022-12-31 | Geography | International | 323,103,000 | USD | 0001673985-25-000011 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 1,622,537,000 | USD | 0001673985-25-000011 |
| FY 2022Yearly · 2022-12-31 | Product | Caprolactam | 319,863,000 | USD | 0001673985-25-000011 |
| FY 2022Yearly · 2022-12-31 | Product | Chemical Intermediates | 482,552,000 | USD | 0001673985-25-000011 |
| FY 2022Yearly · 2022-12-31 | Product | Nylon Resins | 485,241,000 | USD | 0001673985-25-000011 |
| FY 2022Yearly · 2022-12-31 | Product | Plant Nutrients | 657,984,000 | USD | 0001673985-25-000011 |
| FY 2021Yearly · 2021-12-31 | Geography | International | 302,161,000 | USD | 0001673985-24-000014 |
| FY 2021Yearly · 2021-12-31 | Geography | United States | 1,382,464,000 | USD | 0001673985-24-000014 |
| FY 2021Yearly · 2021-12-31 | Product | Ammonium Sulfate Fertilizers | 401,092,000 | USD | 0001673985-24-000014 |
| FY 2021Yearly · 2021-12-31 | Product | Caprolactam | 316,132,000 | USD | 0001673985-24-000014 |
| FY 2021Yearly · 2021-12-31 | Product | Chemical Intermediates | 544,504,000 | USD | 0001673985-24-000014 |
| FY 2021Yearly · 2021-12-31 | Product | Nylon Resins | 422,897,000 | USD | 0001673985-24-000014 |
| FY 2020Yearly · 2020-12-31 | Geography | International | 267,141,000 | USD | 0001673985-23-000007 |
| FY 2020Yearly · 2020-12-31 | Geography | United States | 890,776,000 | USD | 0001673985-23-000007 |
| FY 2020Yearly · 2020-12-31 | Product | Ammonium Sulfate Fertilizers | 287,818,000 | USD | 0001673985-23-000007 |
| FY 2020Yearly · 2020-12-31 | Product | Caprolactam | 216,268,000 | USD | 0001673985-23-000007 |
| FY 2020Yearly · 2020-12-31 | Product | Chemical Intermediates | 369,130,000 | USD | 0001673985-23-000007 |
| FY 2020Yearly · 2020-12-31 | Product | Nylon Resins | 284,701,000 | USD | 0001673985-23-000007 |
| FY 2019Yearly · 2019-12-31 | Geography | International | 239,895,000 | USD | 0001673985-22-000010 |
| FY 2019Yearly · 2019-12-31 | Geography | United States | 1,057,498,000 | USD | 0001673985-22-000010 |
| FY 2019Yearly · 2019-12-31 | Product | Ammonium Sulfate Fertilizers | 299,229,000 | USD | 0001673985-22-000010 |
| FY 2019Yearly · 2019-12-31 | Product | Caprolactam | 278,634,000 | USD | 0001673985-22-000010 |
| FY 2019Yearly · 2019-12-31 | Product | Chemical Intermediates | 368,361,000 | USD | 0001673985-22-000010 |
| FY 2019Yearly · 2019-12-31 | Product | Nylon Resins | 351,169,000 | USD | 0001673985-22-000010 |
| FY 2018Yearly · 2018-12-31 | Geography | International | 244,000,000 | USD | 0001673985-21-000011 |
| FY 2018Yearly · 2018-12-31 | Geography | United States | 1,271,000,000 | USD | 0001673985-21-000011 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.